p38 MAPK Inhibitor NJK14047 Suppresses CDNB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice.

Lee, Ju-Hyun; Son, Seung-Hwan; Kim, Nam-Jung; Im, Dong-Soon

Lee, Ju-Hyun; Son, Seung-Hwan; Kim, Nam-Jung; Im, Dong-Soon.

Afiliação

Lee JH; Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446, Republic of Korea.
Son SH; Department of Basic Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446, Republic of Korea.
Kim NJ; Department of Basic Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446, Republic of Korea.
Im DS; Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02446, Republic of Korea.

Biomol Ther (Seoul) ; 30(6): 501-509, 2022 Nov 01.

Article em En | MEDLINE | ID: mdl-35788499

Palavras-chave

Atopy; Dermatitis; Immunopharmacology; NJK14047; p38 MAPK

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Biomol Ther (Seoul) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google